1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Pharmaceuticals
ScripsAmerica, Inc.

ScripsAmerica, Inc.

SCRCQ
ScripsAmerica, Inc.US flagOther OTC
0.00
USD
- -
- -
14,108.00Market Cap
ScripsAmerica, Inc.
SCRCQ
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
TTM
FRC
0.04
0.12
0.07
0.01
0.24
0.29
Revenue per Share
- -
-0.01
-0.04
-0.17
-0.04
-0.04
Basic EPS, GAAP
- -
-0.02
-0.04
-0.03
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
-0.01
-0.04
-0.2
-0.14
-0.15
Book Value per Share
- -
-0.02
-0.02
-0.07
-0.03
-0.04
Tangible Book Value per Share
79
50
55
68
127
134
Basic Weighted Avg Shares
3
6
4
1
31
39
Sales/Revenue/Turnover
9.83
-2.13
-39.48
-1,311.37
-12.34
-9.02
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
-2
-11
-5
-5
Net Income, GAAP
32.15
- -
- -
- -
- -
- -
Effective Tax Rate (%)
3.94
-5.71
-47.55
-2,012.82
-15.33
-13.13
Profit Margin (%)
- -
- -
1
-2
-2
-2
Working Capital
- -
1
1
1
1
1
LT Debt
- -
- -
- -
-4
-4
-5
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
10.79
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Sep'14
Dec'14
Mar'15
ST Debt
2
- -
1
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
136
137
139
Market Capitalization
11
21
16

Working Capital

FRC

•

in mil. unless spec.
Sep'14
Dec'14
Mar'15
Total Current Assets
6
5
4
Cash, Cash Equivalents & STI
1
- -
- -
Accounts Receivable, Net
3
3
2
Inventories
1
1
1
Total Current Liabilities
5
7
6
Payables & Accruals
3
5
4
ST Debt
2
- -
1
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-2.61%
Free Cash Flow
- -
- -
-132.51%
Net Income, GAAP
- -
- -
-57.74%
Sales/Revenue/Turnover
- -
- -
5,447.5%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
1
2014
1
4
13
14
31
2015
9
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
-0.01
-0.08
-0.03
- -
-0.17
2014
-0.01
- -
0.01
- -
-0.04
2015
-0.01
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2013
- -
- -
- -
- -
- -
2014
- -
- -
- -
- -
- -
2015
- -
- -
- -
- -
- -
Similar Companies
Defence Therapeutics Inc. (DTCFF)
Ligand Pharmaceuticals, Inc. (LGNXZ)
Komipharm International Co., Ltd. (041960.KQ)
Kanabo Group Plc (KNB.L)
Emmessar Biotech & Nutrition Limited (EMMESSA.BO)
Shanghai Pioneer Holding Ltd (1345.HK)
Business
ScripsAmerica, Inc. (SCRCQ) develops and sells non-sterile topical and transdermal pain creams; provides pharmacy dispensing services for individual doctors; offers billing and administrative services to independent pharmacies; and distributes prescription and over-the-counter pharmaceuticals, including generic drugs, to independent pharmacies, hospitals, nursing homes, government agencies, retail outlets, and other medical providers. The company operates through subsidiaries such as Main Avenue Pharmacy Inc., DispenseDoc Inc., and Pharmacy Administration, Inc., serving the U.S. healthcare sector with a focus on pharmaceutical supply chain management from sourcing to delivery. Founded in 2008 and headquartered at 1094 Main Avenue, Clifton, New Jersey, ScripsAmerica filed for Chapter 11 bankruptcy protection on September 7, 2016, with its voluntary petition converted to Chapter 7 liquidation on February 8, 2017.

Company News

APIChatGPT

  • defenseworld.net

    Head to Head Contrast: West Pharmaceutical Services (NYSE:WST) and Scripsamerica (OTCMKTS:SCRCQ)

  • defenseworld.net

    Head-To-Head Survey: Align Technology (NASDAQ:ALGN) and Scripsamerica (OTCMKTS:SCRCQ)